Antengene presents clinical trial results for oncology pipeline at ESMO
Biotechnology company Antengene Corporation presented updated clinical data for drug candidates ATG 022 and ATG 037 during the ESMO 2026 Congress in Madrid
We haven't written up this one. Vietnam Investment Review has the full story — the link below goes straight to it.